A phase III wait-listed randomised controlled trial of novel targeted inter-professional clinical education intervention to improve cancer patients ’ reported pain outcomes (The Cancer Pain Assessment (CPAS) Trial): study protocol

DiscussionIf this mHealth intervention is found to be effective, in addition to improving cancer pain assessment practices, it will provide a readily transferable evidence-based framework that could readily be applied to other evidence practice gaps and a scalable intervention that could be administered simultaneously to multiple clinicians across diverse geographical locations. Moreover, if found to be cost-effective, it will help transform clinical continuing professional development. In summary, this mHealth intervention will provide health services with an opportunity to offer an evidence-based, pedagogically robust, cost-effective, scalable training alternative.Trial registrationAustralian New Zealand Clinical Trials Registry (ANZCTR),ACTRN12618001103257. Registered on 3 July 2018.
Source: Trials - Category: Research Source Type: clinical trials